跳至主要内容
临床试验/NCT07680413
NCT07680413招募中不适用

Real-world Evaluation of the Effectiveness of Immunoglobulin-Histamine Complex; IHC (Histoglob) in the Management of Chronic Urticaria: A Prospective, Multicenter, Observational Study.

Bharat Serums and Vaccines Limited40 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2025年12月31日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
600
试验地点
40
主要终点
Change in clinical improvement as assessed by Urticaria Activity Score (UAS7)

研究概览

简要总结

This is a prospective, multicentre, non-interventional, observational, real-world evidence (RWE) study designed to evaluate the effectiveness and safety of Immunoglobulin/Histamine Complex (IHC) in patients with Chronic Urticaria in India.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
13 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female patients aged ≥13 years.
  • Able and willing to provide written informed consent (or assent where applicable).
  • Diagnosed with chronic urticaria with UAS7 prior to enrollment already on first line of treatment for Chronic Urticaria
  • Prescribed Histoglob injections for the first time at the discretion of treating physician as part of routine car

排除标准

  • Known allergy or hypersensitivity to Histoglob or human immunoglobulin product.
  • Patients with acute allergic attack
  • Pregnant or lactating women.
  • History of malignancy or any condition requiring immunosuppressive therapy other than study indication.
  • Participation in any other clinical study.
  • Any other condition or circumstance that, in the opinion of the study physician, makes the patient unsuitable for study participation

结局指标

主要结局

Change in clinical improvement as assessed by Urticaria Activity Score (UAS7)

时间窗: End of study, approximately 1 year

Proportion of patients achieving UAS7 \<7

次要结局

  • Requirement of Antihistamine ± other non-biologic anti-allergic medications (Pill Burden):(baseline to 2 months)
  • 3. Change in Quality of Life:(Baseline to 2 months)
  • 4. Safety and Tolerability:(Throughout the study period, an average of 1 year)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (40)

Loading locations...

相似试验